Table 4.

Age-specific mortality rates of lymphoma and myeloma by region, 2017 (1/10⁵)

Age group	Eastern China			Central China			Western China
	Both	Male	Female	Both	Male	Female	Both	Male	Female
0–1	0.30	0.56	0.00	0.31	0.57	0.00	0.43	0.54	0.31
1–4	0.20	0.23	0.17	0.25	0.36	0.11	0.35	0.33	0.38
5–9	0.32	0.34	0.29	0.27	0.33	0.20	0.43	0.63	0.23
10–14	0.31	0.28	0.34	0.44	0.60	0.24	0.38	0.45	0.31
15–19	0.32	0.36	0.28	0.51	0.67	0.33	0.53	0.65	0.40
20–24	0.27	0.35	0.17	0.34	0.47	0.21	0.45	0.74	0.16
25–29	0.49	0.72	0.26	0.52	0.67	0.38	0.46	0.48	0.44
30–34	0.84	0.94	0.73	0.79	0.93	0.65	1.00	1.27	0.72
35–39	0.97	1.28	0.65	0.97	1.35	0.59	0.68	0.84	0.52
40–44	1.27	1.35	1.19	1.06	1.39	0.73	1.52	2.06	0.95
45–49	1.81	1.99	1.63	1.77	2.05	1.50	2.23	2.77	1.68
50–54	4.64	5.79	3.43	5.69	6.98	4.36	6.08	7.34	4.74
55–59	4.87	6.13	3.59	4.16	5.55	2.76	3.61	4.62	2.60
60–64	11.56	14.54	8.54	9.36	12.14	6.51	9.33	11.84	6.72
65–69	16.78	21.57	12.12	14.72	18.99	10.44	11.87	14.49	9.23
70–74	18.94	24.18	14.00	15.99	21.21	10.81	16.24	18.95	13.59
75–79	20.16	25.38	15.69	18.15	22.14	14.47	16.53	22.42	11.21
80–84	28.52	36.38	22.69	23.92	30.54	18.29	19.95	27.91	13.17
85+	30.27	43.30	22.53	24.14	34.85	17.31	22.45	31.00	16.74